Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_provenance.
- NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_assertion description "[We conclude that allelic variants of MiRP1 contribute to a significant fraction of cases of drug-induced LQTS through multiple mechanisms and that common sequence variations that increase the risk of life-threatening drug reactions can be clinically silent before drug exposure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_provenance.
- NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_assertion evidence source_evidence_curated NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_provenance.
- NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_assertion SIO_000772 10984545 NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_provenance.
- NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_assertion wasDerivedFrom ctd_human-20130708 NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_provenance.
- NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_assertion wasGeneratedBy ECO_0000218 NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_provenance.
- ctd_human-20130708 importedOn "2013-07-24" NP20762.RAv-IvXoO11hW0-3_LXFrCruVTRjv7RsW5mq29_Dzn_YU130_provenance.